These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 11137247

  • 21. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
    Mills KH, Ryan M, Ryan E, Mahon BP.
    Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
    [Abstract] [Full Text] [Related]

  • 22. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
    Ausiello CM, Lande R, Stefanelli P, Fazio C, Fedele G, Palazzo R, Urbani F, Mastrantonio P.
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):637-42. PubMed ID: 12853397
    [Abstract] [Full Text] [Related]

  • 23. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N, Dore G, Guiso N.
    Vaccine; 2014 Nov 20; 32(49):6597-600. PubMed ID: 25312274
    [Abstract] [Full Text] [Related]

  • 24. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES, O'Hagan DT, Illum L, Barnard A, Mills KH, Redhead K.
    Vaccine; 1995 Apr 20; 13(5):455-62. PubMed ID: 7639014
    [Abstract] [Full Text] [Related]

  • 25. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
    Redhead K, Watkins J, Barnard A, Mills KH.
    Infect Immun; 1993 Aug 20; 61(8):3190-8. PubMed ID: 8335349
    [Abstract] [Full Text] [Related]

  • 26. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.
    van den Berg BM, Beekhuizen H, Mooi FR, van Furth R.
    Infect Immun; 1999 Mar 20; 67(3):1050-5. PubMed ID: 10024542
    [Abstract] [Full Text] [Related]

  • 27. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group.
    Pediatrics; 2001 Nov 20; 108(5):E81. PubMed ID: 11694665
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.
    Prygiel M, Mosiej E, Wdowiak K, Górska P, Polak M, Lis K, Krysztopa-Grzybowska K, Zasada AA.
    Med Microbiol Immunol; 2021 Dec 20; 210(5-6):251-262. PubMed ID: 34338880
    [Abstract] [Full Text] [Related]

  • 29. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

  • 30. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG.
    N Engl J Med; 1996 Feb 08; 334(6):341-8. PubMed ID: 8538704
    [Abstract] [Full Text] [Related]

  • 31. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
    Banus S, Stenger RM, Gremmer ER, Dormans JA, Mooi FR, Kimman TG, Vandebriel RJ.
    BMC Immunol; 2008 May 22; 9():21. PubMed ID: 18498620
    [Abstract] [Full Text] [Related]

  • 32. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K, Pottier G, Smet J, Dirix V, Vermeulen F, De Schutter I, Carollo M, Locht C, Ausiello CM, Mascart F.
    Vaccine; 2013 Dec 17; 32(1):111-8. PubMed ID: 24176499
    [Abstract] [Full Text] [Related]

  • 33. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.
    J Med Microbiol; 2010 Sep 17; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Bottero D, Gaillard ME, Zurita E, Moreno G, Martinez DS, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D.
    Vaccine; 2016 Jun 14; 34(28):3303-9. PubMed ID: 27151884
    [Abstract] [Full Text] [Related]

  • 35. Bordetella pertussis Whole Cell Immunization, Unlike Acellular Immunization, Mimics Naïve Infection by Driving Hematopoietic Stem and Progenitor Cell Expansion in Mice.
    Varney ME, Boehm DT, DeRoos K, Nowak ES, Wong TY, Sen-Kilic E, Bradford SD, Elkins C, Epperly MS, Witt WT, Barbier M, Damron FH.
    Front Immunol; 2018 Jun 14; 9():2376. PubMed ID: 30405604
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity and protective potential of Bordetella pertussis biofilm and its associated antigens in a murine model.
    Dorji D, Graham RM, Singh AK, Ramsay JP, Price P, Lee S.
    Cell Immunol; 2019 Mar 14; 337():42-47. PubMed ID: 30770093
    [Abstract] [Full Text] [Related]

  • 37. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, Graieb A, Rumbo M, Hozbor D.
    Vaccine; 2008 Aug 26; 26(36):4639-46. PubMed ID: 18640169
    [Abstract] [Full Text] [Related]

  • 38. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.
    Pediatrics; 2001 Dec 26; 108(6):E115. PubMed ID: 11731642
    [Abstract] [Full Text] [Related]

  • 39. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS, Coutte L, Raze D, Mooi F, Alexander F, Gorringe A, Mielcarek N, Locht C.
    Vaccine; 2018 Mar 07; 36(11):1345-1352. PubMed ID: 29433898
    [Abstract] [Full Text] [Related]

  • 40. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
    Lavigne MV, Castro M, Andino J, Manghi M.
    Microbes Infect; 2004 Apr 07; 6(5):481-4. PubMed ID: 15109963
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.